Ruxolitinib for Therapy of Graft-versus-Host Disease

Ruxolitinib for the treatment of patients with steroid-refractory GVHD: an introduction to the REACH  trials

(2018) Madan Jagasia et al.   Immunotherapy

Effect of Rituximab on Pulmonary Function in Bronchiolitis Obliterans Syndrome due to Graft-Versus-Host-Disease

(2017) Kyle R. Brownback et al.   LUNG

Acute Graft-versus-Host Disease: Novel Biological Insights

(2016) Takanori Teshima et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

How I treat acute graft-versus-host disease of the gastrointestinal tract and the liver

(2016) G. B. McDonald   BLOOD

Ruxolitinib treatment for GvHD in patients with myelofibrosis

(2016) Y Mori et al.   BONE MARROW TRANSPLANTATION

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report

(2015) Madan H. Jagasia et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Pharmacologic Inhibition of JAK1/JAK2 Signaling Reduces Experimental Murine Acute GVHD While Preserving GVT Effects

(2015) C. Carniti et al.   CLINICAL CANCER RESEARCH

Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey

(2015) R Zeiser et al.   LEUKEMIA

Activity of therapeutic JAK 1/2 blockade in graft-versus-host disease

(2014) S. Spoerl et al.   BLOOD

Pharmacologic Blockade of JAK1/JAK2 Reduces GvHD and Preserves the Graft-Versus-Leukemia Effect

(2014) Jaebok Choi et al.   PLoS One

First- and Second-Line Systemic Treatment of Acute Graft-versus-Host Disease: Recommendations of the American Society of Blood and Marrow Transplantation

(2012) Paul J. Martin et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION